We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Diabetes mellitus triples the risk of TB and increases the probability of adverse TB treatment outcomes
This study showed high levels of stress in more than one third of diabetes mellitus (DM) patients
Effects of cash transfers on health-seeking behaviour, service use, and clinical outcomes among Syrian refugees with type II diabetes in Jordan
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
How to use a cost effectiveness analysis to evaluate your digital health product.
You must tell DVLA if you have hypoglycaemia - download the correct form to let them know
The VIA tool shows how inpatient activity for patients with diabetes differs from a similar patient population without diabetes.
Information explaining the NHS diabetic eye screening programme.
Advice and guidance on the health needs of migrant patients for healthcare practitioners
Information for people referred from diabetic eye screening (DES) because they need regular monitoring or treatment.
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
This workbook was developed by the Health Inequalities National Support Teams (HINST) with 70 local authorities covering populations in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).